Amlovas 2.5 Tablet (15) Information
Amlovas 2.5 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. Other than this, Amlovas 2.5 Tablet (15) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Amlovas 2.5 Tablet (15). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Amlovas 2.5 Tablet (15) have been listed ahead. Such side effects of Amlovas 2.5 Tablet (15) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Amlovas 2.5 Tablet (15) is Severe for pregnant women and Unknown for women who are breastfeeding. It is important to know if Amlovas 2.5 Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Amlovas 2.5 Tablet (15) related warnings section.
Amlovas 2.5 Tablet (15) is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. Some other conditions that can be affected by Amlovas 2.5 Tablet (15) are listed in the contraindications section below.
Besides this, Amlovas 2.5 Tablet (15) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Amlovas 2.5 Tablet (15), it is important to know that it is safe while driving, and is habit-forming.
Amlovas 2.5 Tablet (15) Benefits & Uses
Amlovas 2.5 Tablet (15) is used to treat the following -
Main Benefits
- High BP (Read More - Home Remedies for High Blood Pressure)
Other Benefits
Amlovas 2.5 Tablet (15) Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Amlovas 2.5 Tablet (15) Related Warnings
-
Is the use of Amlovas 2.5 Tablet (15) safe for pregnant women?
Amlovas shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Severe -
Is the use of Amlovas 2.5 Tablet (15) safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Amlovas for breastfeeding women are not known.
Unknown -
What is the effect of Amlovas 2.5 Tablet (15) on the Kidneys?
There can be some harmful effects on your kidneys after taking Amlovas. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
Moderate -
What is the effect of Amlovas 2.5 Tablet (15) on the Liver?
You may experience side effects on your liver after taking Amlovas. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
Moderate -
What is the effect of Amlovas 2.5 Tablet (15) on the Heart?
There are no any side effects of Amlovas for the heart.
Safe
Severe Interaction of Amlovas 2.5 Tablet (15) with Other Drugs
Amlovas 2.5 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Amlovas 2.5 Tablet (15) Contraindications
If you are suffering from any of the following diseases, you should not take Amlovas 2.5 Tablet (15) unless your doctor advises you to do so -
- Low Blood Pressure
- Coronary Artery Disease (CAD)
- Liver Disease
- Heart Failure
- Drug Allergy
- Kidney Disease
Frequently asked Questions about Amlovas 2.5 Tablet (15)
-
Is this Amlovas 2.5 Tablet (15) habit forming or addictive?
Amlovas 2.5 Tablet (15) does not cause addiction.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Amlovas 2.5 Tablet (15) as it does not make you drowsy.
Safe -
Is it safe?
Yes, but consume Amlovas 2.5 Tablet (15) only on doctor's advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Amlovas 2.5 Tablet (15) is unable to treat or cure mental disorders.
No
Amlovas 2.5 Tablet (15) Interactions with Food and Alcohol
-
Interaction between Food and Amlovas 2.5 Tablet (15)
There is no information on the effects of taking Amlovas 2.5 Tablet (15) with food, because this topic has not been scientifically researched yet.
Unknown -
Interaction between Alcohol and Amlovas 2.5 Tablet (15)
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
Mild
See all substitutes for Amlovas
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148